--- title: Buy Kaletra 200mg/50mg 60 Tablets Online description: Kaletra combines Lopinavir and Ritonavir for HIV treatment. This 60-tablet bottle provides antiretroviral therapy from our secure online pharmacy. type: product language: en url: https://liabilis.com/order-kaletra-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 419.99 price_max: 702.99 currency: USD offers: - name: 200/50mg x 60 pills price: 419.99 - name: 200/50mg x 120 pills price: 702.99 --- # Buy Kaletra 200mg/50mg 60 Tablets Online Kaletra is a combination antiretroviral medication containing Lopinavir 200mg and Ritonavir 50mg, used as part of HIV treatment regimens. Originally developed by Abbott Laboratories, this protease inhibitor combination helps control HIV replication and supports immune system function. Ritonavir enhances the effectiveness of Lopinavir by boosting its blood levels. This treatment is essential for adults managing HIV infection. Our pharmacy provides Kaletra in 60-tablet bottles for consistent HIV management. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **200/50mg** | 60 pills | **$419.99** | $7.00 | In Stock | | **200/50mg** | 120 pills | **$702.99** | $5.86 | In Stock | [Buy Now](https://liabilis.com/order-kaletra-online-en.html) ## Introduction Kaletra combines the antiretroviral agents lopinavir (200 mg) and ritonavir (50 mg) in a fixed-dose formulation. The medication is supplied in bottle packs containing 60 tablets. It belongs to the class of protease inhibitors and is used primarily to treat human immunodeficiency virus (HIV) infection. In addition to its approved indication for HIV, lopinavir/ritonavir is sometimes investigated for other viral illnesses, though such uses remain off-label. ## Quick Reference Facts **Active Ingredient** : Lopinavir 200 mg / Ritonavir 50 mg **Form** : Bottle, 60 tab **Primary Uses** : Treatment of HIV-1 infection in combination with other antiretroviral agents ## What is Kaletra? Kaletra is a marketed preparation that contains the protease inhibitors lopinavir and ritonavir in a single tablet. The combination works as a pharmacokinetic booster (ritonavir) and a viral protease blocker (lopinavir). Kaletra was developed by AbbVie (originally Abbott Laboratories) and received regulatory approval in the early 200s for use in adults living with HIV. While Kaletra itself is a brand product, generic formulations containing the same lopinavir 200 mg/ritonavir 50 mg ratio are widely available worldwide, providing a cost-effective alternative for patients and health systems. ## How Kaletra Works Lopinavir inhibits the HIV-1 protease enzyme, preventing the cleavage of viral polyproteins that are essential for producing mature, infectious virions. Ritonavir, administered at a lower dose, is a potent inhibitor of cytochrome P450 3A4 (CYP3A4). By blocking this metabolic pathway, ritonavir raises lopinavir plasma concentrations, allowing once- or twice-daily dosing. After oral administration, the tablets are absorbed in the gastrointestinal tract; peak levels occur within 4-5 hours. The drug-protein binding is high (>98 %), and elimination occurs mainly via hepatic metabolism, with a terminal half-life of approximately 5-6 hours for lopinavir when boosted by ritonavir. ## Conditions Treated with Kaletra - **HIV-1 infection (adults)** The lopinavir/ritonavir combination suppresses viral replication, increases CD4⁺ T-cell counts, and reduces the risk of disease progression when used with a complete antiretroviral regimen. - **Pediatric HIV (≥14 days old)** Formulations are approved for children and infants when weight-based dosing is applied, offering a pediatric option within combination therapy. *These are the only regulatory-approved indications; any other use remains experimental.* ## Is Kaletra the Right Medication for You? Kaletra is appropriate for adults who require a protease-inhibitor component within a fully suppressive antiretroviral regimen. It is especially valuable for patients who have demonstrated tolerability to ritonavir boosting and who benefit from the convenience of a single-tablet regimen. Contraindications include severe hepatic impairment, known hypersensitivity to either component, and concomitant use of strong CYP3A4 inducers (e.g., rifampicin) that could diminish efficacy. Clinicians typically avoid Kaletra in patients with a history of significant lipid abnormalities unless close monitoring is planned. ## Buying Kaletra from [our online pharmacy](https://liabilis.com/order-kaletra-online-en.html) ### Why Choose Our Service? Accessing antiretroviral therapy can be challenging due to cost or geographic limitations. Our pharmacy service provides a reliable avenue to obtain Kaletra at prices that approach wholesale rates, helping patients maintain uninterrupted treatment. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. All sourced batches comply with Good Manufacturing Practice (GMP) standards and undergo third-party verification before shipment. ### Pricing & Access Because generic equivalents of lopinavir/ritonavir are widely produced, we can offer Kaletra at a markedly lower price than many brand-only distributors. This affordability fosters adherence and reduces financial strain for long-term therapy. ### Discreet Delivery Orders are packaged in unmarked envelopes and dispatched via express courier (typically within 7 days) or standard airmail (approximately 3 weeks). Privacy is maintained throughout the fulfillment process, ensuring that personal health information remains confidential. ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing** The usual adult regimen is one tablet taken twice daily with food to enhance absorption. Doses may be adjusted based on body weight, hepatic function, or concomitant medications. - **Missed Dose** If a dose is forgotten and it is less than 6 hours until the next scheduled intake, skip the missed tablet and resume the regular schedule. Do not double-dose. - **Overdose** Symptoms may include nausea, vomiting, abdominal pain, and dizziness. Seek emergency medical attention promptly. Supportive care and monitoring of liver function are recommended. - **Administration Tips** Take tablets with a moderate-fat meal; avoid alcohol excess, as it may increase hepatic strain. Patients should refrain from operating heavy machinery until they know how the drug affects them personally. ## Safety Information ### ⚠️ Who Should Not Take Kaletra - Individuals with severe hepatic impairment (Child-Pugh C). - Patients with documented hypersensitivity to lopinavir, ritonavir, or any tablet excipients. - Concurrent use of strong CYP3A4 inducers (e.g., St. John’s wort, carbamazepine). ### Common Side Effects - **Gastrointestinal:** Diarrhea, nausea, dyspepsia (usually mild to moderate). - **Metabolic:** Elevations in triglycerides and cholesterol; monitor lipid panels periodically. - **Central Nervous System:** Insomnia or vivid dreams, often transient. ### Serious Side Effects (Seek Immediate Medical Help) - Hepatotoxicity: Jaundice, dark urine, right-upper-quadrant pain. - Pancreatitis: Severe abdominal pain radiating to the back, vomiting. - Severe skin reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis. ### Drug & Food Interactions - **CYP3A4 Substrates:** Increased concentrations of certain statins (e.g., simvastatin) may raise the risk of rhabdomyolysis. - **Anticoagulants:** Warfarin effect may be potentiated; monitor INR closely. - **Antacids:** Aluminum-containing formulations can reduce lopinavir absorption; separate administration by at least 2 hours. ## Off-Label and Investigational Uses of Kaletra - **COVID-19 (SARS-CoV-2) Treatment** - Early in the pandemic, lopinavir/ritonavir was evaluated as a potential antiviral; randomized trials reported limited benefit, and guidelines now recommend against routine use. - **Hepatitis C Virus (HCV) Co-infection** - Some studies explored its use as part of salvage therapy, but efficacy data remain insufficient for formal approval. - **Inflammatory Conditions** - Ritonavir’s CYP inhibition has been investigated to boost concentrations of drugs used in oncology, yet clinical evidence is preliminary. All off-label applications should only occur under direct supervision of a qualified healthcare professional. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from moisture and light. - Keep the bottle tightly closed; do not refrigerate. - Dispose of unused tablets according to local pharmacy waste guidelines or return to a medication take-back program. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Kaletra tablets?** Yes, but carry a copy of the prescription or a physician’s letter, and declare the medication at customs if required by the destination country. - **Should I avoid grapefruit while taking Kaletra?** Grapefruit can inhibit CYP3A4, potentially raising lopinavir levels and increasing side-effect risk. It is advisable to limit or avoid grapefruit products. - **Is it safe to drink alcohol while on Kaletra?** Moderate alcohol intake is generally tolerated, but excessive consumption may exacerbate liver toxicity. Discuss personal limits with your clinician. **Product & Formulation Details** - **What do Kaletra tablets look like?** Each tablet is a pink, biconvex tablet bearing the imprint “KLT” on one side and “200/50” on the other, indicating the lopinavir/ritonavir content. - **Can the tablets be split or crushed?** Tablets should be swallowed whole; splitting or crushing can disturb the fixed-dose ratio and affect absorption. **Regulatory & Safety Nuances** - **Will Kaletra show up on a standard drug test?** Routine employment drug screens do not test for antiretrovirals, so Kaletra is unlikely to be detected. - **Is Kaletra safe for athletes subject to anti-doping rules?** Lopinavir and ritonavir are not listed on the World Anti-Doping Agency prohibited list, but athletes should disclose use to their governing bodies. **Scientific & Clinical Curiosity** - **Why is ritonavir included at a lower dose than lopinavir?** Ritonavir’s primary role is to inhibit CYP3A4, boosting lopinavir concentrations; the lower dose minimizes ritonavir-related toxicity while maintaining its boosting effect. - **How does Kaletra compare with older protease inhibitors like indinavir?** Lopinavir/ritonavir generally offers higher genetic barrier to resistance and may have a more favorable lipid profile when combined with appropriate lipid-lowering therapy. ## Glossary **Protease Inhibitor** : A class of antiviral drugs that block the protease enzyme, preventing viral polyprotein processing and the formation of mature virions. **Pharmacokinetic Booster** : An agent (e.g., ritonavir) used at sub-therapeutic doses to inhibit metabolic enzymes, thereby increasing the plasma levels of another drug. **CYP3A4** : A major liver enzyme responsible for metabolizing many medications; inhibition can raise drug concentrations. ## Disclaimer The information provided about **Kaletra** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-kaletra-online-en.html) offers access to **Kaletra** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.